These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28903616)

  • 1. Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol.
    Matsui S; Yasui T; Kasai K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    J Obstet Gynaecol; 2018 Feb; 38(2):231-235. PubMed ID: 28903616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
    Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol.
    Matsui S; Yasui T; Kasai K; Keyama K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    J Obstet Gynaecol; 2017 Jul; 37(5):627-632. PubMed ID: 28317410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
    Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
    Johnson LG; Kraemer RR; Haltom R; Kraemer GR; Gaines HE; Castracane VD
    Fertil Steril; 1997 Nov; 68(5):836-43. PubMed ID: 9389812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating adiponectin with testosterone in women during the menopausal transition.
    Matsui S; Yasui T; Tani A; Kato T; Kunimi K; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    Maturitas; 2012 Nov; 73(3):255-60. PubMed ID: 22939588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause.
    Fonseca E; Basurto L; Velázquez S; Zárate A
    Maturitas; 2001 Jul; 39(1):57-62. PubMed ID: 11451621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
    Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison.
    Castelo-Branco C; Martínez de Osaba MJ; Fortuny A; Iglesias X; González-Merlo J
    J Reprod Med; 1995 Aug; 40(8):556-60. PubMed ID: 7473451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and estrogens in relation to hot flushes during the menopausal transition.
    Øverlie I; Moen MH; Holte A; Finset A
    Maturitas; 2002 Jan; 41(1):69-77. PubMed ID: 11809345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention.
    Conley AJ; Stanczyk FZ; Morrison JH; Borowicz P; Benirschke K; Gee NA; Lasley BL
    Menopause; 2013 Mar; 20(3):322-8. PubMed ID: 23435030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S; Del Ry S; Prontera C; Clerico A
    Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.